| 1 |
26992459 | Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck. | 2016 Apr |
1 |
| 2 |
24138103 | Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat. | 2014 Feb |
2 |
| 3 |
18084312 | Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema. | 2008 Mar |
1 |
| 4 |
17170519 | Pharmacological enhancement of the kallikrein-kinin system promotes anti-fibrotic responses in human mesangial cells. | 2006 |
2 |
| 5 |
15162074 | Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanism. | 2004 Mar |
4 |
| 6 |
11882619 | Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor. | 2002 Feb |
2 |
| 7 |
12487427 | Investigation of bradykinin metabolism in human and rat plasma in the presence of the dual ACE/NEP inhibitors GW660511X and omapatrilat. | 2002 Nov |
1 |
| 8 |
11588409 | Advances in antihypertensive combination therapy: benefits of low-dose thiazide diuretics in conjunction with omapatrilat, a vasopeptidase inhibitor. | 2001 Sep-Oct |
1 |
| 9 |
11716803 | Omapatrilat: a new tool for understanding metabolism of bradykinin at the endothelium level. | 2001 Dec |
1 |
| 10 |
11046097 | Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts. | 2000 Nov |
1 |